The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy Adults
Phase: PHASE2 | Sponsor: University of Calgary | Compound: Psilocybin
- Status
- recruiting
- Institution
- University of Calgary
- Start date
- 2025-09-01
- End date
- 2027-10-01
- Registry ID
- NCT06768944
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.